NCT02907073View on ClinicalTrials.gov

Positron Emission Tomography (PET) Imaging Studies With NIS Reporter

PHASE1/PHASE2TerminatedINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions

MyelomaEndometrial Cancer

Interventions

DRUG

BF4

Single IV dose of 9-11 millicurie (mCi) sodium \[Fluorine-18\] radiolabeled B4\^F

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER

NCT02907073 - Positron Emission Tomography (PET) Imaging Studies With NIS Reporter | Biotech Hunter | Biotech Hunter